Navigation Links
The University of Maryland Baltimore (UMB) and Paragon Bioservices, Inc. Announce the Formation of a Public-Private Stem Cell Technology Consortium

BALTIMORE, April 28, 2011 /PRNewswire/ -- UMB's Center for Stem Cell Biology and Regenerative Medicine and Paragon Bioservices, Inc., a contract research and GMP manufacturing organization with its headquarters at the University of Maryland BioPark, announced today the formation of a public-private partnership for developing and manufacturing stem cell therapies.

Dr. Curt I. Civin, Director of the University of Maryland's Center for Stem Cell Biology and Regenerative Medicine, a pioneer in cancer research and an internationally renowned physician-scientist who has made significant contributions in the field of blood-forming stem cell transplantation, stated "The main objective of the consortium is to accelerate the development of novel strategies for regenerative medicine, including new treatments and preventatives derived from stem cell research."

The Center will collaborate with Paragon Bioservices to establish a core facility that will offer stem cell services on a fee-for-service basis.  The services offered include cell banking and production of a variety of stem cell types.  Stem cells will be available for research purposes and, eventually, for clinical use.

The Consortium is being funded in part by a "Translational Research Award " from the Maryland Biotechnology Center.  According to Dr. Judy Britz, The MBC's Executive Director, "The Maryland Biotechnology Center evaluated 60 proposals and The Consortium effectively competed for its award since it is dedicated to crossing the translational medicine divide, creates a model for sustainability and increases the likelihood of commercialization of new technologies."

Dr. Marco Chacon, Paragon's President & CEO, commented, "It is an honor to work with Dr. Civin as well as a privilege to play a role in the development of interesting technologies that could have a positive impact on public health and the economic development of our community."

The partnership also includes Life Technologies, Inc., a global biotechnology company that is a provider of scientific products and reagents.  LTI already provides innovative solutions for scientists engaging in stem cell research.  So—as part of their corporate commitment to global social responsibility—they will be providing training opportunities for research scientists.

As a partnership for better public health, the Consortium is openly seeking wider participation from other research institutions, State and Federal agencies, and private companies.Contact:

Dr Aaron HeifetzBusiness DevelopmentStem Cell Technologies & Regenerative MedicineAbout Paragon Bioservices, Inc.Paragon Bioservices is a contract research and manufacturing organization (CMO) that provides a comprehensive portfolio of services—from research services and process development to cGMP manufacturing of monoclonal antibodies, therapeutic proteins, vaccines (VLPs), and stem cells.  The corporate focus is to bridge the translational divide and enable protein and cell-based therapeutics to move into clinical trials.

Media Contact for Paragon Bioservices:
Tiberend Strategic Advisors, Inc.
Tamara Bright
Claire Sojda

SOURCE Paragon Bioservices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011
2. Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas
3. Nanocrystal doping developed by Hebrew University researchers enhances semiconductor nanocrystals
4. Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome
5. China PharmaHub In-Licenses Universal Donor Red Blood Cells Technology Exclusively From University of California, San Diego
6. Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition
7. University of Maryland School of Medicine publishes scientific paper on 2001 anthrax attacks
8. Queens University professor uses nanotechnology to prolong machine and engine life
9. Binghamton University nanoscientist chosen for the Air Forces Young Investigator Research Program
10. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
11. Georgia Health Sciences University Clinical Study Shows RyMed InVision-Plus® IV Connector Significantly Decreased Central Venous Catheter Occlusions in Oncology Patients
Post Your Comments:
(Date:6/23/2016)... HOUSTON , June 23, 2016 ... agreement with the Cy-Fair Sports Association to serve ... of the agreement, Houston Methodist Willowbrook will provide ... education and connectivity with association coaches, volunteers, athletes ... partner with the Cy-Fair Sports Association and to ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... ... ... ...
Breaking Biology News(10 mins):